Studying tumor biology in malignant pleural mesothelioma
Part of Cancer, Lungs & breathing clinical trials.
This study collects and analyzes tumor samples from patients with malignant pleural mesothelioma (a cancer of the lung lining caused by asbestos exposure) to better understand the disease and find new treatment approaches. Researchers will examine your tumor at the molecular level to identify patterns that might help predict treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a confirmed diagnosis of malignant pleural mesothelioma (cancer of the lung lining)
- Tumor tissue or other biological samples are available from you for testing
- You do not have an active infection at the time of enrollment
- You do not have an autoimmune disease (a condition where your immune system attacks your own body)
- If you are a woman who could become pregnant, you must be able to confirm you are not currently pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the role of inherited genes in malignant pleural mesothelioma. It includes people recently diagnosed and healthy people who were exposed to asbestos. The goal is to better understand why some people get this cancer.
This study collects tissue samples (from the lining around the lung) from adults with malignant pleural mesothelioma. Researchers will use these samples to check whether certain test markers can predict how the disease may behave, which could guide treatment decisions in the future.
This study collects tissue samples (biopsies) and health information to better understand malignant mesothelioma and certain related solid tumors that may produce a protein called mesothelin. It may help future research and treatments, and you can only join if your diagnosis is confirmed and it’s safe for you to have the tissue taken.
This research study collects tissue samples from people having surgery for pleural mesothelioma (a rare lung cancer) or other lung diseases. The samples are used to better understand the disease and improve future treatments.
This trial uses a test on your tumor tissue to find which chemotherapy drugs work best for you, after standard surgery and heated chemotherapy. It aims to make your treatment more effective by choosing drugs that match your cancer.
This study is looking at the immune system and genes in mesothelioma tumors. It aims to learn more about how the body reacts to the cancer, which may help in finding better treatments in the future.
Hear when a new Malignant Pleural Mesothelioma (MPM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.